Nifty edges higher as insurance, pharma and metals offset bank weakness

Indian equities finished with a modest gain after a cautious opening following the US Federal Reserve’s 25-basis-point rate increase. The domestic market absorbed the global rate shock better than the early trade indicated, helped by buying in insurance, pharmaceutical, metals and infrastructure-linked shares.

HDFC Life led the Nifty gainers, rising 5.14%, while SBI Life gained nearly 3% and Dr Reddy’s Laboratories rose more than 2% in the session. Market reports also identified Bharat Electronics and Eternal among the stronger large-cap counters. The material available does not give a single company-specific trigger for the insurance move; the reported explanation was broad buying in selected defensive and domestic-facing stocks.

Banks were a drag on the broader market. HDFC Bank fell 0.49%, while the banking index underperformed as higher global rates and a firmer dollar kept pressure on rate-sensitive financial shares. Traders also cited easing crude prices and buying in auto and metal stocks as support for the wider market.

The sector pattern reflected both stock-specific buying and the day’s macro backdrop. Pharma and healthcare shares benefited from defensive positioning, while metals and infrastructure-related counters drew interest as crude prices eased from their recent elevated levels. The available reports do not attribute the sector moves to a new domestic policy announcement.

Consumer durables lagged, and FMCG and retail were weaker. The session therefore did not show a uniform risk-on rotation: buying was concentrated in selected defensives, materials and capital-goods-linked names, while parts of financials and consumption remained under pressure.

Global cues were mixed. US equities fell after the Fed’s rate decision, while Asian markets traded unevenly as investors assessed the prospect of another US rate increase. The US 10-year Treasury yield was reported near 5%, and the dollar strengthened after the Fed decision. Those conditions generally raise the financing hurdle for emerging markets and can complicate foreign flows into Indian equities.

Brent crude was reported at $105.504 a barrel as of September 17, after reports that Saudi Arabia had offered additional cargoes through Oman. Traders linked the retreat in crude to reduced concern over immediate supply disruption. For India, a sustained easing in oil would reduce pressure on the import bill and inflation, although the rupee and bond yield remained sensitive to global rates.

Foreign investors sold a net Rs 2,032.61 crore of Indian equities on September 16, while domestic institutions bought a net Rs 3,908.23 crore. These are the latest flow figures in the available material, rather than same-day September 17 data. The domestic buying more than offset the reported foreign selling in the preceding session and helped provide a counterweight to the global risk-off backdrop.

The material reviewed does not identify a new RBI, SEBI or finance ministry decision released during the session. It also does not provide a new Indian CPI, IIP, GST, trade or PMI print for September 17. No India-specific macro surprise was therefore available to displace the global rates narrative.

The main policy cue came from the US Federal Reserve, which raised its benchmark rate by 25 basis points to a range of 3.75% to 4% and signalled the possibility of another increase later in the year. For India, that keeps the focus on the rupee, imported inflation and domestic bond-market conditions rather than on an immediate change in RBI policy.

Corporate news was concentrated in healthcare, diagnostics and infrastructure. Krsnaa Diagnostics executed a 15-year concession agreement with Punjab Health Systems Corporation to develop, operate and maintain PET-CT facilities at four government hospitals. The project is structured as a public-private partnership and marks the company’s entry into PET-CT diagnostic services.

Fortis Healthcare signed definitive agreements to provide services at a more than 400-bed super-specialty hospital in Ashok Vihar, New Delhi. The hospital is expected to begin operations in three to four years, subject to approvals. Highway Infrastructure received a Rs 220.66 crore contract from the Uttar Pradesh Expressways Industrial Development Authority for toll collection and plaza operations on the Gorakhpur Link Expressway.

Venus Pipes & Tubes approved a proposal to raise up to Rs 371.99 crore through a preferential issue, subject to shareholder and regulatory approvals. GNFC appointed Sanjeev Kumar as managing director for a five-year term effective September 9, replacing Rajkumar Beniwal. The available material contains no company earnings comparison with consensus estimates and no new management guidance for the session.

The near-term calendar is dominated by the NSE IPO, which opened on September 17 and is entirely an offer for sale. Existing shareholders are selling 12.64 crore shares, so the exchange itself will not receive the issue proceeds. The offer is scheduled to close on September 21, with a reported listing timetable later in the month.

The primary-market pipeline adds to the competition for liquidity at a time when foreign selling and elevated global yields remain relevant. The available material does not identify a same-day block deal in a large benchmark constituent beyond the reported Groww and smaller-company transactions.